
Loading, please wait...

Loading, please wait...

India is rapidly transforming its medical landscape to ensure affordable healthcare reaches every citizen. Consequently, the government has launched landmark initiatives to strengthen public health systems over the last twelve years. As a result, medical treatments and essential medicines are now within reach for millions of vulnerable families across the nation.
The Ayushman Bharat Pradhan Mantri Jan Arogya Yojana (AB PM-JAY) stands as the world's largest publicly funded health insurance scheme. Notably, it provides a robust health cover of Rs 5 lakh per family annually for secondary and tertiary hospitalizations. Furthermore, in 2024, the government expanded this scheme to include all senior citizens aged 70 years and above, regardless of income. Therefore, elderly citizens now enjoy dedicated financial protection for their age-related medical needs.
Meanwhile, the Pradhan Mantri Bharatiya Janaushadhi Pariyojana (PMBJP) has revolutionized access to essential drugs alongside major insurance reforms. This initiative provides quality generic medicines at prices that are 50% to 80% lower than branded equivalents. Indeed, more than 19,000 Janaushadhi Kendras currently operate across India. Additionally, price caps on cardiac stents and knee implants have heavily reduced out-of-pocket expenses for patients.
Q1: Who is eligible for the expanded Ayushman Bharat scheme?
All senior citizens in India aged 70 years and above are eligible for free health coverage of up to Rs 5 lakh per year, regardless of their family income. Eligible seniors receive a distinct card for this benefit.
Q2: How does the Jan Aushadhi scheme help patients save money?
The Jan Aushadhi scheme provides high-quality generic medicines at 50% to 80% lower costs than market prices. This significantly lowers daily out-of-pocket healthcare expenses for chronic and acute illnesses.
Disclaimer: This content is for informational and educational purposes only. It does not constitute medical advice or replace professional judgment. Refer to the latest local and national guidelines for clinical practice.
References

Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.


India has made major progress in public health over the last 12 years. Flagship schemes like Ayushman Bharat and Jan Aushadhi have drastically lowered treatment and medicine costs for millions of citizens, particularly benefiting vulnerable groups and senior citizens with expanded insurance coverage.
last month

A parliamentary panel has urged the FSSAI to finalise front-of-pack nutrition labelling regulations without further delay. The committee stressed that simple, color-coded indicators for sugar and clear warning labels are vital to combat dietary non-communicable diseases and guide informed consumer choices.
3 days back

A comprehensive analysis of the NFHS-5 data regarding postpartum anemia in India, exploring the prevalence, severity, and the socioeconomic and regional factors contributing to this public health challenge for clinicians seeking to improve maternal health outcomes.
Last week

A study in Greece reveals that 46-80% of heatwave deaths are linked to climate change. This analysis explores the implications for public health and clinical practice, particularly for elderly and vulnerable populations facing rising global temperatures in regions like India.
2 weeks back

Nearly 80% of Indians suffer from inadequate Vitamin D, causing silent bone weakening and sudden fractures. This expert guide reviews why mega-dose therapy is critical for high-risk patients, the key factors driving widespread deficiency, and the mandatory medical evaluations needed to protect skeletal health.
last month

A parliamentary standing committee has directed FSSAI to expedite front-of-pack nutrition labelling regulations. The panel highlighted that over two years of delay since the 2022 draft notification leaves consumers relying on complex numerical labels, urging simple color-coded sugar indicators and warnings.
3 days back